Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
05/2012
05/09/2012CN101899054B Antiatherosclerotic sparstolenin B compound and preparation method thereof
05/09/2012CN101879272B Chinese medicinal compound for treating coronary heart diseases, preparation method and application thereof
05/09/2012CN101856498B Anti-septic shock medicine composition and application thereof
05/09/2012CN101830911B Thienopyridine derivatives, preparation method and application thereof
05/09/2012CN101735305B Synthesizing method of L-carnosine
05/09/2012CN101696166B Preparation method for danshen root salvianolic acid A
05/09/2012CN101633644B N3 alkylated benzimidazole derivatives as mek inhibitors
05/09/2012CN101574337B Prevention and treatment of microcirculation disturbance induced by endotoxin with compatible combination of salvianolic acid B and hydroxyethyl starch
05/09/2012CN101522633B 6-substituted isoquinoline derivatives as ROCK-I inhibitors
05/09/2012CN101511796B Imidazole derivative
05/09/2012CN101503458B Small molecule polypeptide for preventing and treating angiogenesis and use thereof
05/09/2012CN101439059B Ginkgo leaf extract drop and preparation method thereof
05/09/2012CN101428094B Uses of medicament composition in preparing medicament for improving brain microcirculation disorder
05/09/2012CN101332230B Prunella plant extract, and use thereof
05/09/2012CN101332229B Prunella plant extract and pharmaceutical use thereof
05/09/2012CN101301432B Chinese medicinal composition for treating cerebral hemorrhage
05/09/2012CN101248054B Thiazole derivatives and use thereof
05/09/2012CN101214281B Method for producing cistanche salsa extract
05/09/2012CN101213195B Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect
05/09/2012CN101199657B Medicament for treating vasculitis
05/09/2012CN101185676B Ointment medicine for treating hemorrhoid
05/09/2012CN101022807B Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin
05/08/2012US8173805 sEH inhibitors and their use
05/08/2012US8173782 Fusion protein comprising growth hormone and growth hormone receptor
05/08/2012US8173779 Neutralizing human anti-IGFR antibody
05/08/2012US8173665 I-pheny 1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use
05/08/2012US8173654 Triazolopyridazine compounds
05/08/2012US8173606 Sulfated oligosaccharide derivatives
05/08/2012US8173596 Administering prouroguanylin and a diuretic; kidney disease, heart disease, liver disease, hypertension
05/08/2012US8173384 Methods for analyzing or processing a heparin sample
05/08/2012US8173129 Methods and compositions for treating autoimmune diseases
05/08/2012US8173126 Blood VEGF level-lowering agent containing IL-6 antagonist as the active ingredient
05/08/2012CA2659947C New derivatives of diosmetin, process for the preparation thereof and pharmaceutical compounds containing them
05/08/2012CA2593171C Pharmaceutical composition and method for neoangiogenesis/revascularization useful in treating ischemic heart diseases
05/08/2012CA2514356C Novel inhibitors of formation of advanced glycation endproducts (ages)
05/08/2012CA2507027C Isoquinoline compounds and medicinal use thereof
05/08/2012CA2459224C 1,3-benzothiazinone derivatives and the use thereof
05/08/2012CA2377661C Use of fatty acid derivative for the treatment of external secretion disorders
05/08/2012CA2353574C Analogues of glp-1
05/08/2012CA2340593C Use of vegf-c or vegf-d gene or protein to prevent restenosis
05/08/2012CA2163211C Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
05/03/2012WO2012058598A1 Methods of preventing and treating hyperlipidemia or atherosclerosis
05/03/2012WO2012058585A2 Methods of treatment with natriuretic peptides
05/03/2012WO2012058529A2 Metalloenzyme inhibitor compounds
05/03/2012WO2012058132A1 Soluble guanylate cyclase activators
05/03/2012WO2012057613A1 Method for preventing myocardial infarction-related complications
05/03/2012WO2012057492A2 Rapamycin formulation using recombinant high-density lipoprotein including apolipoprotein a-i and a mutant thereof
05/03/2012WO2012057103A1 Pharmaceutical composition
05/03/2012WO2012056976A1 Modulator of activity of adenylate cyclase
05/03/2012WO2012056509A1 Pharmaceutical composition
05/03/2012WO2012056478A1 Oxazole and isoxazole crac modulators
05/03/2012WO2012056205A1 Peptide
05/03/2012WO2012056048A1 Treatment of inflammation
05/03/2012WO2012055971A1 Microvesicles derived from atheroprotective endothelial cells for the treatment and prevention of atherosclerotic diseases
05/03/2012WO2012054988A1 Seleno-compounds and therapeutic uses thereof
05/03/2012WO2012032417A3 Compositions comprising a fatty acid oil mixture, a free fatty acid, and a statin
05/03/2012WO2012032415A3 Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form, a surfactant, and a statin
05/03/2012WO2012032414A3 Compositions comprising a fatty acid oil mixture, a surfactant, and a statin
05/03/2012WO2012006525A3 Pkc activators and anticoagulant in regimen for treating stroke
05/03/2012WO2011107608A8 Heterocyclic amides as rock inhibitors
05/03/2012US20120109044 Prevention of myocardial infraction induced ventricular expansion and remodeling
05/03/2012US20120108670 Formoterol tartrate process and polymorph
05/03/2012US20120108664 Transdermal delivery of beneficial substances effected by a hostile biophysical environment
05/03/2012US20120108654 Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosa
05/03/2012US20120108646 RNAi Modulation Of TGF-BETA And Therapeutic Uses Thereof
05/03/2012US20120108639 Nitrogen-containing aromatic heterocyclyl compound
05/03/2012US20120108637 Fused Bicyclic-Substituted Amines as Histamine-3 Receptor Ligands
05/03/2012US20120108636 Allosteric Enhancers of th A1 Adenosine Receptor
05/03/2012US20120108627 Imidazo [4,5-c]quinoline derivatives and their use in the treatment of tumors and/or inflammation
05/03/2012US20120108617 Methods and compositions involving (s)-bucindolol
05/03/2012US20120108614 Compounds and compositions for treating chemical warfare agent-induced injuries
05/03/2012US20120108613 Compounds and compositions for treating chemical warfare agent-induced injuries
05/03/2012US20120108611 5, 6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists
05/03/2012US20120108610 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial
05/03/2012US20120108609 Dihydrooxazol-2-amine derivatives
05/03/2012US20120108607 Optically active 3-[(phenylpiperazin-1-yl)alkyl]-3- alkyl-oxindole derivatives having cns activity
05/03/2012US20120108606 Carboxamide, Sulfonamide and Amine Compounds and Methods for Using The Same
05/03/2012US20120108604 Processes for preparing amine salts of sildenafil-analogues and use thereof
05/03/2012US20120108603 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
05/03/2012US20120108599 Methods and compositions for the treatment of metabolic disorders
05/03/2012US20120108598 Sitagliptin synthesis
05/03/2012US20120108597 Azaquinazolinediones Chymase Inhibitors
05/03/2012US20120108595 Platelet-activating factor receptor antagonists
05/03/2012US20120108594 PROCESS FOR PREPARING SALTS OF 4-[[5-[(CYCLOPROPYLAMINO)CARBONYL]-2-METHYLPHENYL]AMINO]-5-METHYL-N-PROPYLPYRROLO[2,1-f][1,2,4]TRIAZINE-6-CARBOXAMIDE AND NOVEL STABLE FORMS PRODUCED THEREIN
05/03/2012US20120108588 Novel 3-amido-pyrrolo[3,4-c]pyrazole-5(1h, 4h,6h) carbaldehyde derivatives
05/03/2012US20120108587 Aza- and Diaza-Phthalazine Compounds as P38 Map Kinase Modulators and Methods of Use Thereof
05/03/2012US20120108584 2h or 3h-benzo[e]indazol-1-yl carbamate derivatives, the preparation and therapeutic use thereof
05/03/2012US20120108583 Tricyclic Compounds As mPGES-1 Inhibitors
05/03/2012US20120108573 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
05/03/2012US20120108571 Substituted phenoxy n-alkylated thiazolidinediones as estrogen related receptor-alpha modulators
05/03/2012US20120108566 Nicotinamides as jak kinase modulators
05/03/2012US20120108558 Treatment of Hot Flashes
05/03/2012US20120108550 Use of Derivatives of Polyunsaturated Fatty Acids as Medicaments
05/03/2012US20120108548 Molecular tweezers for the treatment of amyloid-related diseases
05/03/2012US20120108514 Long acting atrial natriuretic peptide (la-anp) and methods for use thereof
05/03/2012US20120108507 Methods for In Vivo Cell Reprogramming
05/03/2012US20120108505 Thiophenes as glucagon receptor antagonists, compositions, and methods for their use
05/03/2012US20120108495 Method of Inhibiting Smooth Muscle Cell Proliferation by Using Reconstituted HDL
05/03/2012US20120107897 Double-stranded oligonucleotides
05/03/2012US20120107833 Antibody specific for a mammalian sphingosine kinase type 2 isoform protein and methods of use thereof
1 ... 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 ... 1595